VistaGen Therapeutics Inc

XNAS: VTGN

Download real time

2.79 0.02 (0.72%)

51.39% Fall from 52W High

76,653 XNAS Volume

XNAS 21 Mar, 2025 5:30 PM (EDT)

80.5

Market Cap

Below industry Median

0.2

Beta 1Year

Very Low volatility

VistaGen Therapeutics Inc - VTGN - stock price prediction, stock price target, analyst ratings from 4 analysts

VistaGen Therapeutics Inc has a share price target of US$ 13, revenue growth forecast of -37.7%, and profit growth estimate of -87.0% for FY25, based on top 4 analyst calls.

Forecaster Screeners